Provided by Tiger Fintech (Singapore) Pte. Ltd.

ACADIA Pharmaceuticals

22.44
-0.1800-0.80%
Volume:1.61M
Turnover:36.47M
Market Cap:3.79B
PE:16.93
High:22.92
Open:22.55
Low:22.05
Close:22.62
52wk High:26.65
52wk Low:13.40
Shares:168.71M
Float Shares:115.85M
Volume Ratio:1.07
T/O Rate:1.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.33
EPS(LYR):1.37
ROE:33.18%
ROA:5.27%
PB:4.60
PE(LYR):16.42

Loading ...

Canaccord Genuity Reaffirms Their Buy Rating on ACADIA Pharmaceuticals (ACAD)

TIPRANKS
·
Sep 25

U.S. RESEARCH ROUNDUP- Apogee Therapeutics, Intel, Northern Trust

Reuters
·
Sep 25

ACADIA Pharmaceuticals Inc : Deutsche Bank Cuts Target Price to $29 From $35

THOMSON REUTERS
·
Sep 25

ACADIA Pharmaceuticals Inc : TD Cowen Cuts Target Price to $35 From $39

THOMSON REUTERS
·
Sep 25

ACADIA Pharmaceuticals (ACAD) Receives a Hold from Oppenheimer

TIPRANKS
·
Sep 25

ACADIA Pharmaceuticals: Growth Potential Despite Setbacks with Promising Pipeline and Core Business Expansion

TIPRANKS
·
Sep 25

ACADIA Pharmaceuticals (ACAD) Receives a Buy from Robert W. Baird

TIPRANKS
·
Sep 25

ACADIA Pharmaceuticals (ACAD) Receives a Hold from Stifel Nicolaus

TIPRANKS
·
Sep 25

Acadia Pharmaceuticals PWS miss ‘disappointing but expected,’ says Leerink

TIPRANKS
·
Sep 24

ACADIA Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
Sep 24

Soleno shares jump following competitor Acadia’s trial miss

TIPRANKS
·
Sep 24

ACADIA Pharmaceuticals Down Nearly 11%, on Pace for Largest Percent Decrease Since August 2024 -- Data Talk

Dow Jones
·
Sep 24

Optimistic Outlook for ACADIA Pharmaceuticals Despite Recent Setback: Buy Rating and $32 Price Target

TIPRANKS
·
Sep 24

BUZZ-Soleno Therapeutics rises after rival's rare disease drug fails late-stage study

Reuters
·
Sep 24

Acadia Pharmaceuticals falls -11.2%

TIPRANKS
·
Sep 24

Sector Update: Health Care Stocks Steady Pre-Bell Wednesday

MT Newswires Live
·
Sep 24

Balanced Hold Rating for ACADIA Pharmaceuticals Amid Trial Setback and Growth Potential

TIPRANKS
·
Sep 24

Morgan Stanley sees ‘small impact’ on Acadia valuation from ACP-101 failure

TIPRANKS
·
Sep 24

Soleno Therapeutics Shares Rise Pre-Bell After Rival Therapy Fails to Meet Primary Endpoint

MT Newswires Live
·
Sep 24

BUZZ-Acadia falls as rare disease therapy fails late-stage trial

Reuters
·
Sep 24